CA junks Sanofi appeal over Dengvaxia case
MANILA, Philippines – The Court of Appeals (CA) has denied the plea of pharmaceutical company Sanofi Pasteur Inc. (SPI) to rule on the merit of its petition that challenged the government’s revocation of its certificates of product registration (CPRs) for the controversial Dengvaxia vaccine. Dengvaxia was tagged as responsible for the death of several children
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.